Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SURMODICS INC Director's Dealing 2021

Dec 2, 2021

32845_dirs_2021-12-02_0c0fb76d-366e-499a-a9b3-dfae7cb67115.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-11-30

Reporting Person: OLSON CHARLES W (Senior VP of Bus Dev, Med Dev)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-30 Common Stock F 650 $43.93 Disposed 37822 Direct
2021-11-30 Common Stock A 4552 $0.00 Acquired 42374 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-30 Employee Stock Option (right to buy) $43.93 A 18337 Acquired 2028-11-30 Common Stock (18337) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 800 Indirect

Footnotes

F1: The award vests in four equal installments on each of the first four anniversaries of the November 30, 2021 grant date.